证券记录 · 已归档季度
HCA
HCA Healthcare, Inc. · Healthcare · Medical - Care Facilities
20被追踪持有人
-1Δ持有人
22.69M持有股份
$9.21B报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -4.8% ·
股份流向 -17.6% ·
净新建仓位 -5.0%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 164 | -3 | 101.14M | $39.43B | +4 | −6 |
| Q1 2026 | 169 | +3 | 106.88M | $50.54B | +5 | −3 |
| Q4 2025 | 165 | -1 | 114.61M | $53.42B | +1 | −1 |
| Q3 2025 | 26 | +1 | 64.51M | $27.48B | +1 | −1 |
| Q2 2025 | 23 | +1 | 60.26M | $23.08B | +1 | — |
| Q1 2025 | 19 | -2 | 30.59M | $10.56B | +1 | −3 |
| Q4 2024 | 21 | 0 | 31.21M | $9.36B | +1 | −1 |
| Q3 2024 | 20 | -1 | 22.69M | $9.21B | +1 | −2 |
| Q2 2024 | 21 | — | 27.53M | $8.84B | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 7.05M | -34.6% | $2.87B | 0.5% | ▼ Trim | 2 | SEC ↗ ×9 |
| 2 | Geode Capital Management ✦ (被动) | 3.82M | -2.1% | $1.55B | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 3 | Capital World Investors ✦ | 2.91M | +0.8% | $1.18B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 4 | Norges Bank ✦ (被动) | 2.88M | +0.4% | $1.17B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 5 | Arrowstreet Capital ✦ | 2.55M | +1.2% | $1.04B | 0.9% | ▲ Add | 2 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.41M | -41.3% | $571.16M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 7 | Viking Global Investors ✦ | 698.03K | +6.7% | $283.70M | 1.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Harris Associates (Oakmark) ✦ | 325.44K | -12.5% | $132.27M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 9 | Bridgewater Associates ✦ | 250.04K | -15.5% | $101.62M | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 240.51K | -4.8% | $97.75M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 192.53K | +35.0% | $78.25M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 172.37K | +140.0% | $69.00M | 0.1% | ▲ Add | 2 | SEC ↗ ×4 |
| 13 | Markel Group ✦ | 50.93K | +45.1% | $20.70M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 14 | GAMCO Investors ✦ | 37.37K | -2.2% | $15.19M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 35.15K | -30.6% | $14.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 31.58K | +15.0% | $12.84M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 17 | Gotham Asset Management ✦ | 22.33K | +1.0% | $9.08M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 3.86K | 新增 | $1.57M | 0.0% | New | 1 | SEC ↗ |
| 19 | Marshall Wace ✦ | 3.50K | +118.8% | $1.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 633 | -19.2% | $257,302 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Two Sigma Investments | $1.57M | 0.0% |
已清仓
| Glenview Capital | $62.84M | 曾为 1.3% |
| Renaissance Technologies | $4.11M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 700 股份, $331 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据